KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlisle Companies (CSL) Cash & Equivalents (2016 - 2025)

Carlisle Companies' Cash & Equivalents history spans 17 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 47.59% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 47.59%, while the annual FY2025 figure was $1.1 billion, 47.59% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $1.1 billion at Carlisle Companies, up from $1.1 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.7 billion in Q2 2024 and bottomed at $68.4 million in Q2 2025.
  • The 5-year median for Cash & Equivalents is $488.2 million (2023), against an average of $615.1 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 1317.22% in 2024 before it plummeted 96.06% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $324.4 million in 2021, then increased by 12.45% to $364.8 million in 2022, then skyrocketed by 58.09% to $576.7 million in 2023, then soared by 30.66% to $753.5 million in 2024, then soared by 47.59% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CSL's Cash & Equivalents are $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $68.4 million (Q2 2025).